Results
|
4721.
|
Expression of eukaryotic initiation factor 5A and hypusine forming enzymes in glioblastoma patient samples: implications for new targeted therapies. [electronic resource] by
- Preukschas, Michael
- Hagel, Christian
- Schulte, Alexander
- Weber, Kristoffer
- Lamszus, Katrin
- Sievert, Henning
- Pällmann, Nora
- Bokemeyer, Carsten
- Hauber, Joachim
- Braig, Melanie
- Balabanov, Stefan
Producer: 20130129
In:
PloS one vol. 7
Availability: No items available.
|
|
4722.
|
|
|
4723.
|
Relapse in medulloblastoma: what can be done after abandoning high-dose chemotherapy? A mono-institutional experience. [electronic resource] by
- Massimino, Maura
- Casanova, Michela
- Polastri, Daniela
- Biassoni, Veronica
- Modena, Piergiorgio
- Pecori, Emilia
- Schiavello, Elisabetta
- De Pava, Marco Vajna
- Indini, Alice
- Rampini, Paolo
- Bauer, Dario
- Catania, Serena
- Podda, Marta
- Gandola, Lorenza
Producer: 20161213
In:
Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery vol. 29
Availability: No items available.
|
|
4724.
|
|
|
4725.
|
|
|
4726.
|
|
|
4727.
|
Cilengitide combined with standard treatment for patients with newly diagnosed glioblastoma with methylated MGMT promoter (CENTRIC EORTC 26071-22072 study): a multicentre, randomised, open-label, phase 3 trial. [electronic resource] by
- Stupp, Roger
- Hegi, Monika E
- Gorlia, Thierry
- Erridge, Sara C
- Perry, James
- Hong, Yong-Kil
- Aldape, Kenneth D
- Lhermitte, Benoit
- Pietsch, Torsten
- Grujicic, Danica
- Steinbach, Joachim Peter
- Wick, Wolfgang
- Tarnawski, Rafał
- Nam, Do-Hyun
- Hau, Peter
- Weyerbrock, Astrid
- Taphoorn, Martin J B
- Shen, Chiung-Chyi
- Rao, Nalini
- Thurzo, László
- Herrlinger, Ulrich
- Gupta, Tejpal
- Kortmann, Rolf-Dieter
- Adamska, Krystyna
- McBain, Catherine
- Brandes, Alba A
- Tonn, Joerg Christian
- Schnell, Oliver
- Wiegel, Thomas
- Kim, Chae-Yong
- Nabors, Louis Burt
- Reardon, David A
- van den Bent, Martin J
- Hicking, Christine
- Markivskyy, Andriy
- Picard, Martin
- Weller, Michael
Producer: 20150114
In:
The Lancet. Oncology vol. 15
Availability: No items available.
|
|
4728.
|
|
|
4729.
|
IKBKE enhances TMZ-chemoresistance through upregulation of MGMT expression in glioblastoma. [electronic resource] by
- Guo, G
- Sun, Y
- Hong, R
- Xiong, J
- Lu, Y
- Liu, Y
- Lu, J
- Zhang, Z
- Guo, C
- Nan, Y
- Huang, Q
Producer: 20210329
In:
Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico vol. 22
Availability: No items available.
|
|
4730.
|
|
|
4731.
|
|
|
4732.
|
MGMT modulates glioblastoma angiogenesis and response to the tyrosine kinase inhibitor sunitinib. [electronic resource] by
- Chahal, Manik
- Xu, Yaoxian
- Lesniak, David
- Graham, Kathryn
- Famulski, Konrad
- Christensen, James G
- Aghi, Manish
- Jacques, Amanda
- Murray, David
- Sabri, Siham
- Abdulkarim, Bassam
Producer: 20101112
In:
Neuro-oncology vol. 12
Availability: No items available.
|
|
4733.
|
|
|
4734.
|
Phase 2 study of dose-intense temozolomide in recurrent glioblastoma. [electronic resource] by
- Norden, Andrew D
- Lesser, Glenn J
- Drappatz, Jan
- Ligon, Keith L
- Hammond, Samantha N
- Lee, Eudocia Q
- Reardon, David R
- Fadul, Camilo E
- Plotkin, Scott R
- Batchelor, Tracy T
- Zhu, Jay-Jiguang
- Beroukhim, Rameen
- Muzikansky, Alona
- Doherty, Lisa
- Lafrankie, Debra
- Smith, Katrina
- Tafoya, Vida
- Lis, Rosina
- Stack, Edward C
- Rosenfeld, Myrna R
- Wen, Patrick Y
Producer: 20140205
In:
Neuro-oncology vol. 15
Availability: No items available.
|
|
4735.
|
|
|
4736.
|
|
|
4737.
|
E7449: A dual inhibitor of PARP1/2 and tankyrase1/2 inhibits growth of DNA repair deficient tumors and antagonizes Wnt signaling. [electronic resource] by
- McGonigle, Sharon
- Chen, Zhihong
- Wu, Jiayi
- Chang, Paul
- Kolber-Simonds, Donna
- Ackermann, Karen
- Twine, Natalie C
- Shie, Jue-Lon
- Miu, Jingzang Tao
- Huang, Kuan-Chun
- Moniz, George A
- Nomoto, Kenichi
Producer: 20160928
In:
Oncotarget vol. 6
Availability: No items available.
|
|
4738.
|
Low c-Met expression levels are prognostic for and predict the benefits of temozolomide chemotherapy in malignant gliomas. [electronic resource] by
- Li, Ming-Yang
- Yang, Pei
- Liu, Yan-Wei
- Zhang, Chuan-Bao
- Wang, Kuan-Yu
- Wang, Yin-Yan
- Yao, Kun
- Zhang, Wei
- Qiu, Xiao-Guang
- Li, Wen-Bin
- Peng, Xiao-Xia
- Wang, Yong-Zhi
- Jiang, Tao
Producer: 20161226
In:
Scientific reports vol. 6
Availability: No items available.
|
|
4739.
|
Sorafenib, a multikinase inhibitor, enhances the response of melanoma to regional chemotherapy. [electronic resource] by
- Augustine, Christina K
- Toshimitsu, Hiroaki
- Jung, Sin-Ho
- Zipfel, Patricia A
- Yoo, Jin S
- Yoshimoto, Yasunori
- Selim, M Angelica
- Burchette, James
- Beasley, Georgia M
- McMahon, Nicole
- Padussis, James
- Pruitt, Scott K
- Ali-Osman, Francis
- Tyler, Douglas S
Producer: 20101104
In:
Molecular cancer therapeutics vol. 9
Availability: No items available.
|
|
4740.
|
Increased xCT expression correlates with tumor invasion and outcome in patients with glioblastomas. [electronic resource] by
- Takeuchi, Satoru
- Wada, Kojiro
- Toyooka, Terushige
- Shinomiya, Nariyoshi
- Shimazaki, Hideyuki
- Nakanishi, Kuniaki
- Nagatani, Kimihiro
- Otani, Naoki
- Osada, Hideo
- Uozumi, Yoichi
- Matsuo, Hirotaka
- Nawashiro, Hiroshi
Producer: 20130708
In:
Neurosurgery vol. 72
Availability: No items available.
|